- MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial. Journal of magnetic resonance imaging : JMRI. 2016 In Process GET IT
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL.
Times cited: 5
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.
Times cited: 122